Company news

Verici DX PLC news in 2022

Verici DX PLC's news releases, calls and decks from 2022, newest first.

View company

Director/PDMR Shareholding

December 7, 2022

Correction: Holding(s) in Company

December 1, 2022

Product rebranding as TutiviaT

October 3, 2022

Positive results for Clarava from validation study

September 6, 2022

Result of AGM and voting results

June 27, 2022

Distribution of Verici Dx shares by EKF

June 20, 2022

CEO Video Interview

June 15, 2022

Further data from TutevaT validation study

June 14, 2022

Commercial Team Appointments

June 9, 2022

Posting of Annual Report & Accounts

May 25, 2022

Results of TutevaT clinical validation study

May 12, 2022

Clinical Validation Study Update

April 1, 2022

Close of Subscription and Fundraise Update

March 11, 2022

Result of Fundraise

March 4, 2022

Proposed Fundraise

March 4, 2022

Successful completion of analytical validation

February 15, 2022

Progress and strategy update

January 12, 2022

ClaravaT and TutevaT complete testing requirements

January 6, 2022

Collaboration with Illumina

January 5, 2022

Grant of two CPT Codes by AMA

January 4, 2022

Calls in 2022

Decks in 2022